Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cannabidiol (Epidiolex) (1 trial)
tetrahydrocannabinol (1 trial)
autologous microbiome (1 trial)
Cachexia (Phase 3)
Neoplasms (Phase 3)
Substance Withdrawal Syndrome (Phase 2)
Wasting Syndrome (Phase 3)
Trials (2 total)
Trial APIs (3 total)